NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Life Science Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Life Science Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiology



Beta arrestin activity studied, need for angiotensin receptor revealed



January 25th, 2005

According to a study from the United States, a stable interaction between beta-arrestin 2 and angiotensin type 1A (AT(1A)) receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.

"Receptors not only leads to receptor desensitization and endocytosis but also elicits additional signaling processes. We recently proposed that stimulation of the AT(1A) receptor results in independent beta-arrestin 2- and G protein-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation.

"Here we utilize two AT(1A) mutant receptors to study these independent pathways, one truncated at residue 324,...


Source: Life Science Weekly (2005-01-25)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login